Dawnrays Pharmaceutical Holdings Ltd. (HK:2348) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dawnrays Pharmaceutical Holdings Ltd. has announced the grant of 16 million share options to 17 eligible employees, including the CEO, under their 2023 Share Option Scheme. The options are exercisable over six years with a staggered vesting schedule, starting at HK$1.25 per share. This incentive aims to motivate employees’ performance and commitment to the company’s success.
For further insights into HK:2348 stock, check out TipRanks’ Stock Analysis page.